Clincosm LogoSign in Get a demo

adalimumab

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adalimumab Trial in Cypress, South Miami, Salt Lake City (ABP 501-HCF, ABP 501-LCF)

Completed
  • Adalimumab
  • ABP 501-HCF
  • ABP 501-LCF
  • Cypress, California
  • +2 more
Jun 9, 2023

A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

Recruiting
  • Vogt-Koyanagi-Harada Disease
  • Adalimumab
  • Tianjin, Tianjin, China
    Tianjin Medical University Eye Hospital
Oct 19, 2022

Uveitis, Adalimumab Trial in Guangzhou (reduction or discontinuation of Adalimumab)

Recruiting
  • Uveitis
  • Adalimumab
  • reduction or discontinuation of Adalimumab
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Dec 9, 2021

Takayasu Arteritis, Tocilizumab, Adalimumab Trial in Shanghai (Tocilizumab, Adalimumab)

Recruiting
  • Takayasu Arteritis
  • +3 more
  • Tocilizumab
  • Adalimumab
  • Shanghai, Shanghai, China
    Department of Rheumatology in Zhongshan hospital, Fudan Universi
Aug 7, 2021

Generalized Pustular Psoriasis (GPP), Adalimumab, Japanese Trial (Adalimumab)

Completed
Has Results
  • Generalized Pustular Psoriasis (GPP)
  • +2 more
  • (no location specified)
Jul 16, 2018